Sanara MedTech Inc.

NasdaqCM:SMTI Stock Report

Market Cap: US$274.6m

Sanara MedTech Future Growth

Future criteria checks 3/6

Sanara MedTech is forecast to grow earnings at 124.9% per annum. EPS is expected to grow by 124.5% per annum.

Key information

124.9%

Earnings growth rate

124.5%

EPS growth rate

Medical Equipment earnings growth16.1%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

Low

Last updated26 Mar 2024

Recent future growth updates

Sanara MedTech Inc. (NASDAQ:SMTI) Analysts Are Pretty Bullish On The Stock After Recent Results

Mar 22
Sanara MedTech Inc. (NASDAQ:SMTI) Analysts Are Pretty Bullish On The Stock After Recent Results

Recent updates

Is Sanara MedTech (NASDAQ:SMTI) Using Too Much Debt?

Nov 15
Is Sanara MedTech (NASDAQ:SMTI) Using Too Much Debt?

Investors Still Waiting For A Pull Back In Sanara MedTech Inc. (NASDAQ:SMTI)

May 22
Investors Still Waiting For A Pull Back In Sanara MedTech Inc. (NASDAQ:SMTI)

Sanara MedTech Inc. (NASDAQ:SMTI) Analysts Are Pretty Bullish On The Stock After Recent Results

Mar 22
Sanara MedTech Inc. (NASDAQ:SMTI) Analysts Are Pretty Bullish On The Stock After Recent Results

Sanara MedTech: Differentiated Offering With Niche Wound Care Exposure

Sep 06

Sanara MedTech reports Q2 results

Aug 15

Here's Why We're Not At All Concerned With Sanara MedTech's (NASDAQ:SMTI) Cash Burn Situation

Dec 31
Here's Why We're Not At All Concerned With Sanara MedTech's (NASDAQ:SMTI) Cash Burn Situation

Sanara MedTech: Technology For Faster Healing Wounds

Dec 08

Sanara Medtech inks exclusive partnership with Pixalere Healthcare

Jun 04

Companies Like Sanara MedTech (NASDAQ:SMTI) Can Afford To Invest In Growth

May 18
Companies Like Sanara MedTech (NASDAQ:SMTI) Can Afford To Invest In Growth

Neil Cataldi From Blueprint Discusses Sanara MedTech

May 03

The Sanara MedTech (NASDAQ:SMTI) Share Price Has Soared 510%, Delighting Many Shareholders

Feb 19
The Sanara MedTech (NASDAQ:SMTI) Share Price Has Soared 510%, Delighting Many Shareholders

Is Sanara MedTech Inc. (NASDAQ:SMTI) Popular Amongst Insiders?

Dec 28
Is Sanara MedTech Inc. (NASDAQ:SMTI) Popular Amongst Insiders?

Earnings and Revenue Growth Forecasts

NasdaqCM:SMTI - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202478-2N/AN/A1
12/31/202365-4-4-3N/A
9/30/202363-8-3-3N/A
6/30/202360-9-4-6N/A
3/31/202354-6-6-5N/A
12/31/202246-8-6-6N/A
9/30/202238-7-8-7N/A
6/30/202230-8-9-6N/A
3/31/202227-10-6-6N/A
12/31/202124-8-6-5N/A
9/30/202122-5-5-4N/A
6/30/202120-4-3-3N/A
3/31/202117-4-4-3N/A
12/31/202016-4-6-4N/A
9/30/202014-6-6-4N/A
6/30/202013-5-6-4N/A
3/31/202013-4-6-4N/A
12/31/201912-3-4-2N/A
9/30/201911-1-2-1N/A
6/30/2019100-1-1N/A
3/31/20199000N/A
12/31/20189001N/A
9/30/20188011N/A
6/30/20187000N/A
3/31/20187000N/A
12/31/20176000N/A
9/30/201760N/A0N/A
6/30/201760N/A1N/A
3/31/20176-1N/A0N/A
12/31/20166-1N/A0N/A
9/30/20164-1N/A0N/A
6/30/20164-2N/A-1N/A
3/31/20163-1N/A-1N/A
12/31/20153-2N/A-1N/A
9/30/20153-1N/A-1N/A
6/30/20153-2N/A-1N/A
3/31/20153-2N/A-1N/A
12/31/20143-3N/A-2N/A
9/30/20142-4N/A-2N/A
6/30/20142-5N/A-2N/A
3/31/20142-4N/A-2N/A
12/31/20132-4N/A-2N/A
9/30/20132-3N/A-1N/A
6/30/20132-3N/A-1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: SMTI is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.4%).

Earnings vs Market: SMTI is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: SMTI is expected to become profitable in the next 3 years.

Revenue vs Market: Insufficient data to determine if SMTI's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if SMTI's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if SMTI's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.